Article
Microenvironment of metastasis reveals key predictors of PD-1 blockade response in renal cell carcinoma
2023-07-19
Abstract excerpt
Immune checkpoint blockade (ICB) therapies have improved the overall survival (OS) of many patients with advanced cancers. However, the response rate to ICB varies widely among patients, exposing non-responders to potentially severe immune-related adverse events. The discovery of new biomarkers to identify patients responding to ICB is now a critical need in the clinic. We therefore investigated the tumor microenv...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f640a5d2-181d-5a17-acd6-61b41b6b3cbb
- DOI
- 10.1101/2023.07.17.548676
